Procter & Gamble (NYSE:PG) Price Target Lowered to $185.00 at Raymond James

Procter & Gamble (NYSE:PG - Get Free Report) had its price target lowered by analysts at Raymond James from $190.00 to $185.00 in a research report issued on Friday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Raymond James' price target would indicate a potential upside of 14.88% from the company's previous close.

Several other equities analysts have also issued reports on PG. UBS Group reiterated a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. Citigroup reduced their price objective on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a research report on Friday. Piper Sandler reissued an "underperform" rating on shares of Procter & Gamble in a report on Friday. Stifel Nicolaus raised their price target on shares of Procter & Gamble from $161.00 to $165.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Finally, Royal Bank of Canada raised Procter & Gamble from a "sector perform" rating to an "outperform" rating and raised their target price for the stock from $164.00 to $177.00 in a research report on Friday. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $180.79.

Procter & Gamble Stock Up 0.9 %

Shares of NYSE:PG traded up $1.51 during midday trading on Friday, reaching $161.04. The company had a trading volume of 12,892,765 shares, compared to its average volume of 7,124,247. Procter & Gamble has a 1-year low of $156.58 and a 1-year high of $180.43. The stock has a market cap of $377.61 billion, a PE ratio of 25.64, a P/E/G ratio of 3.76 and a beta of 0.43. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The business's 50 day moving average price is $168.16 and its 200 day moving average price is $168.32.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.03). The firm had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. During the same period in the previous year, the business posted $1.52 earnings per share. Research analysts forecast that Procter & Gamble will post 6.91 EPS for the current fiscal year.

Insider Activity at Procter & Gamble

In other news, CEO Gary A. Coombe sold 18,000 shares of the business's stock in a transaction that occurred on Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total value of $3,089,880.00. Following the transaction, the chief executive officer now owns 22,051 shares in the company, valued at $3,785,274.66. The trade was a 44.94 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.18% of the stock is owned by insiders.

Institutional Investors Weigh In On Procter & Gamble

A number of hedge funds have recently made changes to their positions in PG. Norges Bank bought a new position in shares of Procter & Gamble during the 4th quarter valued at approximately $5,244,463,000. GAMMA Investing LLC increased its position in Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after buying an additional 7,913,335 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Procter & Gamble in the fourth quarter valued at $1,010,685,000. Bank Julius Baer & Co. Ltd Zurich grew its stake in shares of Procter & Gamble by 1,195.1% during the 4th quarter. Bank Julius Baer & Co. Ltd Zurich now owns 3,222,585 shares of the company's stock worth $580,596,000 after acquiring an additional 2,973,757 shares during the period. Finally, Capital Research Global Investors increased its holdings in Procter & Gamble by 62.5% in the 4th quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock worth $1,240,294,000 after acquiring an additional 2,846,560 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.